Cullinan Therapeutics has announced that its lead asset has aced a midstage lung cancer trial—but the biotech is keeping the ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Pregnancy comes with unique health risks and considerations, but pregnant people also continue to experience the same health ...

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

Mab’s pipeline pivot had a sting in the tail. Weeks after shifting its focus, the biotech said Wednesday that it has reduced ...

The FDA’s move to lift the hold on Zentalis Pharmaceuticals’ sole clinical-stage drug may have been good news for the biotech ...

Zimmer Biomet is taking steps to expand its foot and ankle orthopedics business, with a $1.1 billion deal to acquire the ...